Tafasitamab and lenalidomide for relapsed/refractory diffuse large B-cell lymphoma in a patient on chronic intermittent hemodialysis

Moore, DC; Eagers, KA; Janes, A; Pineda-Roman, M

Moore, DC (通讯作者)，Atrium Hlth, Levine Canc Inst, Dept Pharm, 100 Med Pk Dr, Concord, NC 28025 USA.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2023; 29 (1): 239

Abstract

Introduction Tafasitamab is an anti-CD19 monoclonal antibody indicated for the treatment of relapsed/refractory diffuse large B-cell lymphoma to be gi......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索